The medical device maker flags a drop in stand-alone procedures for its Watchman heart implant, hitting its near-term growth ...

Boston Scientific Corp (NYSE:BSX) fell over 6% Wednesday after management lowered its full-year guidance during a presentation at Bernstein.

By Kamal Choudhury May 27 (Reuters) - Boston Scientific shares fell about 12% on Wednesday to their lowest in more than two ...

The medical device giant just opened its wallet for a stake in a privately held company with a groundbreaking product.

Investors weigh softer WATCHMAN and urology demand against a still-active device pipeline and capital deployment moves, today ...

CNBC’s Jim Cramer explains why he is keeping an eye on shares of Boston Scientific.

Boston Scientific Corporation (NYSE:BSX) is one of the best medical technology stocks to buy right now. On May 19, TD Cowen ...

With the study results, Boston Scientific plans a regulatory submission for the intravascular lithotripsy treatment for ...

Boston Scientific (NYSE:BSX) announced today that it invested $1.5 billion in transcatheter aortic valve replacement (TAVR) ...

Boston Scientific (NYSE:BSX) today announced the first patient treated with its Seismiq IVL system in the ELEGANCE registry.

Boston Scientific invests $1.5B in Georgia startup MiRus for a 34% stake and exclusive rights to acquire its heart valve ...

BostonSci secures rights to acquire MiRus' SIEGEL TAVR system with $1.5B equity stake and potential buyout, marking its 3rd ...